Skip to content

The Brain Metabolism of Unpredictable Signals

Quantifying the Brain Metabolism Underlying Task-Based BOLD Imaging

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05756335
Enrollment
24
Registered
2023-03-06
Start date
2024-04-05
Completion date
2026-02-12
Last updated
2026-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Brain metabolism, Positron Emission Tomography, Magnetic Resonance Imaging

Brief summary

The investigators will be studying brain glucose and oxygen metabolism using hybrid PET/fMRI imaging to better understand how decoupling between brain glucose and oxygen metabolism relates to the processing of unpredictable sensory signals.

Detailed description

The proposed research consists of one experiment, combining positron emission tomography (PET) and magnetic resonance imaging (MRI) techniques to simultaneously estimate the cerebral metabolic rates of glucose (CMRglc) and oxygen (CMRO2), and their ratio (oxygen:glucose index; OGI). These outcome measures will be collected in the context of a behavioral intervention presenting subjects with predictable and unpredictable stimuli, and attended and unattended stimuli. Functional PET uses a slow infusion of 2-\[18F\]-fluro-deoxyglucose (FDG) to estimate regional CMRglc, measuring relative changes in radiotracer uptake between blocks of task and rest. Dual-calibrated fMRI uses a sequence of hyperoxic (increased O2) and hypercapnic (increased CO2) challenges, along with a specialized sequence of MRI scans (estimating cerebral blood flow and blood-oxygen level-dependent signal) to estimate absolute CMRO2. All subjects will be scanned, and each will complete the same behavioral intervention. First, the investigators will aim to assess the reliability of this hybrid imaging technique by having subjects complete two identical scan sessions. Second, the investigators will deliver a behavioral intervention to test the relationship between stimuli predictability, CMRglc, CMRO2, and OGI. This experimental design is capable of producing effects observable in single subjects, and prior studies using fPET and dual-calibrated fMRI have produced effect sizes that our sample size is more than adequate to detect.

Interventions

BEHAVIORAL(Un)predictable and (un)attended stimuli

Subjects will complete four task conditions in each scan session: (1) Visual Unpredictable, (2) Visual Predictable, (3) Auditory Unpredictable, and (4) Auditory Predictable. In visual and auditory conditions subjects attend to visual or auditory stimuli and ignore the other domain, pressing a button when they detect an infrequently occurring stimulus inversion in the target domain. In unpredictable and predictable conditions, the attended domain either presents random (unpredictable) stimuli, or the same face or word stimuli repeated (predictable).

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults aged 21-35. * No contraindications to MRI or PET scanning. * Right-handed. * Fluent to speak, read, and understand English.

Exclusion criteria

* Adults unable to consent * Contraindications to fMRI scanning and PET scanning (including the presence of a cardiac pacemaker or pacemaker wires, metallic particles in the body, vascular clips in the head or previous neurosurgery, prosthetic heart valves, claustrophobia) * Inability to lie motionless in the scanner * Pregnancy, seeking or suspecting pregnancy, or breastfeeding * History of major head trauma * Intracranial lesion * Cardiovascular disorders, including heart disorders or high blood pressure \[\>155/95\] * Breathing problems such as severe asthma, emphysema, or pulmonary disease * Bleeding disorder, or use of anticoagulants * Bladder obstruction, urinary problems, or history of impaired elimination * Known kidney or liver problems * Past severe COVID-19 infection * Intestinal blockage * Raynaud syndrome * Anemia * Peripheral nerve injury * Diabetes * Glaucoma * Current or recent use of medications (neurological or psychiatric) affecting brain function * Current or past history of major medical, neurological, or psychiatric condition * Current or past history of chronic pain (assessed at the discretion of PI) * Current smoker * Body mass index above 35 * Research-related radiation exposure exceeds current Radiology Department guidelines * Lack of current health insurance coverage * Employed under the direct supervision of the investigators conducting the research * Unwilling or unable to cooperate with breathing maneuvers required during the gas challenge * Respiratory or cardiac limitations to breathing at 20 L/min

Design outcomes

Primary

MeasureTime frameDescription
Brain positron emission tomography (PET) imaging signalsafter PET image analysis and with study completion, an average of 1 yearChanges in glucose metabolism will be quantified from brain PET images
Functional magnetic resonance imaging (fMRI) signalsafter fMRI image analysis and with study completion, an average of 1 yearChanges in oxygen metabolism will be quantified from dual-calibrated fMRI
Oxygen-glucose indexafter PET/fMRI image analysis and with study completion, an average of 1 yearRatio of cerebral metabolic rates of glucose and oxygen from PET and fMRI signals

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORChristin Y Sander, PhD

Athinoula A. Martinos Center for Biomedical Imaging

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 3, 2026